Crinetics Pharmaceuticals, Inc. (CRNX) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Crinetics Pharmaceuticals, Inc. (CRNX) Bundle
Discover Crinetics Pharmaceuticals, Inc. (CRNX) true value with our professional-grade DCF Calculator! Adjust key assumptions, explore various scenarios, and evaluate how changes affect Crinetics Pharmaceuticals, Inc. (CRNX) valuation – all within a single Excel template.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.2 | .1 | 1.1 | 4.7 | 4.0 | 4.9 | 6.0 | 7.4 | 9.1 | 11.1 |
| Revenue Growth, % | 0 | -94.05 | 1418.31 | 339.42 | -15.28 | 22.67 | 22.67 | 22.67 | 22.67 | 22.67 |
| EBITDA | -49.3 | -72.6 | -106.8 | -166.9 | -221.5 | -4.9 | -6.0 | -7.4 | -9.1 | -11.1 |
| EBITDA, % | -4133.19 | -102233.8 | -9905.38 | -3523.31 | -5519.81 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | 1.1 | 1.2 | 1.3 | 1.4 | 1.1 | 3.4 | 4.2 | 5.2 | 6.4 | 7.8 |
| Depreciation, % | 93.29 | 1726.76 | 117.07 | 29.32 | 27.36 | 70 | 70 | 70 | 70 | 70 |
| EBIT | -50.4 | -73.8 | -108.0 | -168.3 | -222.6 | -4.9 | -6.0 | -7.4 | -9.1 | -11.1 |
| EBIT, % | -4226.49 | -103960.56 | -10022.45 | -3552.63 | -5547.17 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 118.4 | 170.9 | 333.7 | 334.4 | 558.6 | 4.9 | 6.0 | 7.4 | 9.1 | 11.1 |
| Total Cash, percent | .0 | .2 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | 1.8 | 2.0 | .0 | 9.4 | 3.0 | 3.6 | 4.4 | 5.5 | 6.7 |
| Account Receivables, % | 0 | 2581.69 | 188.22 | 0 | 233.02 | 60 | 60 | 60 | 60 | 60 |
| Inventories | -1.4 | -1.8 | 8.1 | .0 | .0 | -1.0 | -1.2 | -1.5 | -1.8 | -2.2 |
| Inventories, % | -115.51 | -2581.69 | 748.79 | 0 | 0 | -20 | -20 | -20 | -20 | -20 |
| Accounts Payable | 2.7 | 3.5 | 3.4 | 6.9 | 6.5 | 4.9 | 6.0 | 7.4 | 9.1 | 11.1 |
| Accounts Payable, % | 226.15 | 4912.68 | 317.44 | 145.3 | 163.17 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | -.5 | -.2 | -.4 | -1.7 | -4.7 | -3.1 | -3.8 | -4.7 | -5.8 | -7.1 |
| Capital Expenditure, % | -41.24 | -261.97 | -40.45 | -34.96 | -116.82 | -63.33 | -63.33 | -63.33 | -63.33 | -63.33 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -49.5 | -72.9 | -107.1 | -164.2 | -222.6 | -4.9 | -6.0 | -7.3 | -9.0 | -11.0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -44.8 | -72.4 | -116.5 | -150.9 | -235.9 | 1.2 | -4.9 | -6.0 | -7.4 | -9.0 |
| WACC, % | 7.32 | 7.32 | 7.32 | 7.32 | 7.32 | 7.32 | 7.32 | 7.32 | 7.32 | 7.32 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -19.8 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -9 | |||||||||
| Terminal Value | -173 | |||||||||
| Present Terminal Value | -122 | |||||||||
| Enterprise Value | -141 | |||||||||
| Net Debt | -3 | |||||||||
| Equity Value | -138 | |||||||||
| Diluted Shares Outstanding, MM | 58 | |||||||||
| Equity Value Per Share | -2.38 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real CRNX financials.
- Real-World Data: Historical data and forward-looking estimates (as highlighted in the yellow cells).
- Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe the effect of your inputs on Crinetics Pharmaceuticals’ valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- Comprehensive CRNX Data: Pre-filled with Crinetics Pharmaceuticals’ historical financials and future projections.
- Customizable Inputs: Modify revenue growth rates, profit margins, WACC, tax rates, and capital expenditures to suit your analysis.
- Interactive Valuation Model: Automatic recalculations of Net Present Value (NPV) and intrinsic value as you adjust your inputs.
- Scenario Analysis: Develop various forecasting scenarios to explore different valuation results.
- Intuitive Interface: Designed for ease of use, catering to both industry professionals and newcomers.
How It Works
- 1. Access the Template: Download and open the Excel file featuring Crinetics Pharmaceuticals, Inc. (CRNX) preloaded data.
- 2. Adjust Assumptions: Modify essential inputs such as growth projections, WACC, and capital expenditures.
- 3. See Results Immediately: The DCF model automatically computes intrinsic value and NPV.
- 4. Explore Scenarios: Analyze various forecasts to evaluate different valuation possibilities.
- 5. Present with Assurance: Deliver professional valuation insights to inform your strategic decisions.
Why Choose This Calculator for Crinetics Pharmaceuticals, Inc. (CRNX)?
- User-Friendly Interface: Tailored for both novice users and seasoned professionals.
- Customizable Inputs: Easily adjust parameters to suit your specific analysis needs.
- Real-Time Feedback: Observe immediate updates to Crinetics' valuation as you change inputs.
- Preloaded Data: Comes with Crinetics’ actual financial information for swift evaluations.
- Relied Upon by Experts: A favorite among investors and analysts for making well-informed choices.
Who Should Use This Product?
- Pharmaceutical Students: Explore drug development processes and apply them with real-world data.
- Researchers: Integrate advanced pharmaceutical models into academic studies or publications.
- Investors: Evaluate your investment strategies and assess valuation metrics for Crinetics Pharmaceuticals (CRNX).
- Market Analysts: Enhance your analysis with a tailored, user-friendly financial model specific to the biotech sector.
- Healthcare Entrepreneurs: Understand how biotech firms like Crinetics Pharmaceuticals are evaluated in the market.
What the Template Contains
- Historical Data: Includes Crinetics Pharmaceuticals, Inc.'s (CRNX) past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Crinetics Pharmaceuticals, Inc.'s (CRNX) intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Crinetics Pharmaceuticals, Inc.'s (CRNX) financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.